| __timestamp | Corcept Therapeutics Incorporated | GSK plc |
|---|---|---|
| Wednesday, January 1, 2014 | 34916000 | 8246000000 |
| Thursday, January 1, 2015 | 36949000 | 9232000000 |
| Friday, January 1, 2016 | 45240000 | 9366000000 |
| Sunday, January 1, 2017 | 62416000 | 9672000000 |
| Monday, January 1, 2018 | 81289000 | 9915000000 |
| Tuesday, January 1, 2019 | 100359000 | 11402000000 |
| Wednesday, January 1, 2020 | 105326000 | 11456000000 |
| Friday, January 1, 2021 | 122356000 | 10975000000 |
| Saturday, January 1, 2022 | 152848000 | 8372000000 |
| Sunday, January 1, 2023 | 184259000 | 9385000000 |
Unveiling the hidden dimensions of data
In the competitive world of pharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for profitability. From 2014 to 2023, GSK plc and Corcept Therapeutics Incorporated have shown distinct strategies in handling these costs. GSK, a global healthcare giant, consistently reported SG&A expenses in the range of $8.2 billion to $11.5 billion annually. In contrast, Corcept, a smaller player, managed its expenses from $34.9 million to $184.3 million over the same period.
Despite the vast difference in scale, Corcept's SG&A expenses grew by over 400%, reflecting its aggressive expansion strategy. Meanwhile, GSK's expenses remained relatively stable, indicating a focus on efficiency. This comparison highlights the diverse approaches companies take in managing operational costs, with GSK emphasizing stability and Corcept focusing on growth.
SG&A Efficiency Analysis: Comparing AbbVie Inc. and Corcept Therapeutics Incorporated
Gross Profit Comparison: GSK plc and Corcept Therapeutics Incorporated Trends
Breaking Down SG&A Expenses: GSK plc vs ADMA Biologics, Inc.
GSK plc vs Amicus Therapeutics, Inc.: SG&A Expense Trends
GSK plc and Merus N.V.: SG&A Spending Patterns Compared
Comparing SG&A Expenses: GSK plc vs Arrowhead Pharmaceuticals, Inc. Trends and Insights
Cost Management Insights: SG&A Expenses for Takeda Pharmaceutical Company Limited and Corcept Therapeutics Incorporated
Operational Costs Compared: SG&A Analysis of Viatris Inc. and Corcept Therapeutics Incorporated
Comparing SG&A Expenses: Bio-Techne Corporation vs Corcept Therapeutics Incorporated Trends and Insights
Cost Management Insights: SG&A Expenses for Lantheus Holdings, Inc. and Corcept Therapeutics Incorporated
Comparing SG&A Expenses: Corcept Therapeutics Incorporated vs ACADIA Pharmaceuticals Inc. Trends and Insights
Comparing SG&A Expenses: Corcept Therapeutics Incorporated vs BioCryst Pharmaceuticals, Inc. Trends and Insights